AORT vs TMCI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

AORT

38.7
AI Score
VS
AORT Wins

TMCI

35.3
AI Score

Investment Advisor Scores

AORT

39score
Recommendation
SELL

TMCI

35score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AORT TMCI Winner
Revenue 365.88M 140.83M AORT
Net Income -20.02M -46.40M AORT
Gross Margin 63.4% 79.1% TMCI
Net Margin -5.5% -32.9% AORT
Operating Income 370,000 -43.66M AORT
ROE -4.5% -75.3% AORT
ROA -1.9% -25.9% AORT
Total Assets 1.04B 179.30M AORT
Cash 48.40M 7.76M AORT
Debt/Equity 0.81 0.91 AORT
Current Ratio 4.42 2.58 AORT
Free Cash Flow -36.43M -8.15M TMCI

Relative Price Performance (Last 90 Days)

AORT 1M: -6.1% · 3M: -28.5% TMCI 1M: +19.0% · 3M: +2.7%

Current Technical Phase

AORT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 40

RSI (14): 39.5 · Price: $20.47

TMCI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.2 · Price: $4.88

Fundamentals Snapshot

Metric AORT TMCI
Market Cap — —
Forward P/E 39.4 -5.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.6% 0.8%
Operating Margin 0.0% -0.3%
EPS -0.36 -0.85
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AORT is currently the stronger investment candidate, winning 10 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.